Websites Offer Poor Information About C-Section

This article originally appeared here.
Share this content:
Websites Offer Poor Information About C-Section
Websites Offer Poor Information About C-Section

WEDNESDAY, April 8, 2015 (HealthDay News) -- The quality and completeness of Internet information about cesarean sections is poor, according to a Brazilian study published in the April issue of BJOG: An International Journal of Obstetrics and Gynaecology.

B.T.S. Fioretti, from the São Paulo Federal University in Brazil, and colleagues entered 'cesarean delivery' and 25 synonyms into the most popular search engines in Brazil, a country with very high rates of cesarean delivery. Assessments of 176 websites from the first three pages of hits were made using the DISCERN instrument and a content checklist.

The researchers found that 30 percent of the pages were of poor or very poor quality and 47 percent were of moderate quality. Low-scoring pages were due to questions related to reliability of the information. Top topics covered were as follows: indications for cesarean section (80 percent of websites); short-term maternal risks (80 percent); and potential benefits of cesarean section (56 percent), including maternal and doctor convenience. Perinatal risks were mentioned on less than half of the websites and less than one-third mentioned long-term maternal risks, such as uterine rupture (17 percent) or placenta praevia/accreta (12 percent) in future pregnancies.

"Pending improvement of these resources, obstetricians should warn pregnant women about these facts and encourage them to discuss what they have read on the Internet about cesarean section," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »